Verdant Bioscience

Verdant
Verdant Bioscience
Verdant Bioscience
Verdant Bioscience

Beneficial interest AvH : 42.00%

AvH contact: Tom Bamelis

verdantbioscience.com

Verdant Bioscience develops oil palm F1 hybrid varieties and other supporting technologies that underpin significant yield increases and productivity enhancements.

 

Key financial highlights

USD 5.3 million

Turnover (2023)

USD -3.3 million

Net result (2023)

392

Employees (2023)